{
    "2021-12-23": [
        [
            {
                "time": "",
                "original_text": "贝达药业贝伐珠单抗注射液（贝安汀?）新增四项适应症申请获受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗",
                        "注射液",
                        "贝安汀",
                        "新增",
                        "适应症",
                        "申请",
                        "受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "喜讯！贝达药业荣获“2021年浙江本土民营跨国公司经营50强”",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "喜讯",
                        "荣获",
                        "2021年",
                        "浙江",
                        "本土",
                        "民营",
                        "跨国公司",
                        "经营50强"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：贝伐珠单抗注射液（贝安汀）新增适应症补充申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝伐珠单抗",
                        "注射液",
                        "贝安汀",
                        "新增",
                        "适应症",
                        "补充",
                        "申请",
                        "受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}